11.06.2020 23:00:00

Insights on the Ocular Implants Global Market to 2027 - Players Include Johnson & Johnson, Morcher and STAAR Surgical Company Among Others

DUBLIN, June 11, 2020 /PRNewswire/ -- The "Ocular Implants - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis and the looming economic recession, the Ocular Implants market worldwide will grow by a projected US$5.3 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 5.3%. Intraocular Lenses, one of the segments analyzed and sized in this study, is forecast to grow at over 6.4% and reach a market size of US$4.8 Billion by the end of the analysis period.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.

An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Intraocular Lenses market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 6.4% CAGR. Germany will add over US$234.6 Million to Europe's size over the next 7 to 8 years. In addition, over US$236.1 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Intraocular Lenses segment will reach a market size of US$437.9 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Ocular Implants market.

Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 5.6% over the next couple of years and add approximately US$886.2 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Ocular Implants market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • Alcon, a Novartis Company
  • Bausch and Lomb, Inc.
  • Carl Zeiss AG
  • Johnson & Johnson
  • Morcher GmbH
  • STAAR Surgical Company

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Ocular Implants Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION
Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/x398xw

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/insights-on-the-ocular-implants-global-market-to-2027---players-include-johnson--johnson-morcher-and-staar-surgical-company-among-others-301074601.html

SOURCE Research and Markets

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!